株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のインスリンデリバリーデバイス市場:簡素化されたインスリンポンプと、低価格インスリンペンによる市場成長の促進

Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers

発行 GBI Research 商品コード 299030
出版日 ページ情報 英文 121 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
世界のインスリンデリバリーデバイス市場:簡素化されたインスリンポンプと、低価格インスリンペンによる市場成長の促進 Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers
出版日: 2014年04月30日 ページ情報: 英文 121 Pages
概要

世界のインスリンデリバリーデバイスの市場規模は、2012年に88億米ドル、2019年には138億米ドルに達すると予想されています。またこの間の年平均成長率(CAGR)は7%と推計されています。先進国(米国・欧州など)では、インスリンポンプの人気拡大や、人工膵臓装置などの開発・普及が市場成長の促進要因となっています。一方、新興国市場では糖尿病の有病率上昇やデリバリーデバイスの普及率の低さが、市場成長を促す要因となっています。昨今では人工膵臓装置の開発などに関する企業間の事業提携が進んでいます。今後、先進国では最新技術・装置の普及が進む一方、新興国(中国・インドなど)ではインスリンペンなどの従来型・低価格装置の普及が進んでいくものと思われます。

当レポートでは、全世界のインスリンデリバリーデバイス(インスリン注入用装置)の市場について分析し、装置の特徴・定義や最新動向、主な促進・抑制要因、全世界および主要国の市場動向(過去の実績値と今後の予測値)、主要企業のプロファイル(事業概要・上市済み製品)、現在開発中のパイプライン製品の概要、昨今の資本取引・業界再編の動きなどを調査して、その結果を概略以下の構成でお届けします。

第1章 目次

第2章 イントロダクション

第3章 糖尿病:疾患概要

第4章 糖尿病:疫学

第5章 インスリンデリバリーデバイスの概要

  • インスリンペン(再利用型/使い捨て型、ニードル)
  • インスリンポンプ(従来式/使い捨て型)
  • インスリンシリンジ
  • 従来式インスリンポンプの付属品
  • インスリンデリバリーデバイスの比較

第6章 市場の特徴

  • 市場収益額の実績値(過去8年間分)
  • 市場収益額の予測値(今後8年間分)
  • 主要企業の市場シェア(全世界、地域別)
  • 市場の主な傾向
    • 全自動式人工膵臓装置の開発に向けた各企業の動き
    • 事業提携による製品開発の促進
    • 即効性吸入インスリン:人工膵臓装置での利用に向けた研究
  • 市場のダイナミクス
    • 市場促進要因
    • 市場抑制要因

第7章 部門別の市場分析・予測

  • インスリンペン:収益額の実績値(過去8年間分)
  • インスリンペン:収益額の予測値(今後8年間分)
  • インスリンポンプ:収益額の実績値(過去8年間分)
  • インスリンポンプ:収益額の予測値(今後8年間分)
  • インスリンシリンジ:収益額の実績値(過去8年間分)
  • インスリンシリンジ:収益額の予測値(今後8年間分)
  • 従来型インスリンポンプの付属品:収益額の実績値(過去8年間分)
  • 従来型インスリンポンプの付属品:収益額の予測値(今後8年間分)

第8章 国別の市場分析・予測

  • クロスカントリー分析
  • 各国の市場動向(金額・数量ベース、通算15年間分)
    • 米国
    • 日本
    • ドイツ
    • フランス
    • 英国
    • スペイン
    • イタリア
    • カナダ
    • 中国
    • オーストラリア
    • インド
    • ブラジル

第9章 医療費償還制度

  • 米国
  • 欧州諸国(全11ヶ国)
  • アジア太平洋地域諸国

第10章 競争環境

  • 代表的なインスリンポンプの比較:サイズ・カラーのオプション
  • 代表的なインスリンポンプの比較:ベーサル量/ボーラス量の仕様
  • 代表的なインスリンポンプの比較:ボーラス量計算機能オプションと操作法
  • Novo Nordisk(Novo A/Sの子会社)
  • Sanofi
  • Eli Lilly
  • Medtronic
  • Becton, Dickinson and Company
  • Animas
  • F. Hoffmann-La Roche
  • Insulet
  • Asante Solutions
  • Abbott Laboratories
  • Ypsomed
  • Owen Mumford
  • Bioject Medical Technologies
  • Injex - Equidyne Systems
  • Antares Pharma
  • Tandem Diabetes Care
  • Tonghua Dongbao Pharmaceutical
  • Shanghai Fosun Pharmaceutical

第11章 製品パイプラインの分析

  • パイプライン製品の一覧
    • インスリンポンプ
    • インスリンペン
  • 主なパイプライン製品のプロファイル(全36製品)

第12章 業界再編の動き

  • 資本取引のサマリー(過去10年間分)
  • 主な資本取引(過去5年間分、全7件)

第13章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Summary

GBI Research's report, "Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers" examines the market, competitive landscape, and trends for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories. It provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape, analyzes each segment's pipeline products and gives details of important mergers and acquisitions. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Scope

  • The markets of 12 key geographies are covered: US, Canada, UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
  • Information on market size for the four insulin delivery devices market segments: insulin pens, insulin pumps, insulin syringes and traditional insulin pump accessories.
  • Annual market revenue data forecast to 2019 and company share data for 2012.
  • Qualitative analysis of key trends in the insulin delivery devices market.
  • Information on the competitive landscape and the leading technologies of key players: Novo Nordisk, Medtronic, Sanofi, Eli Lilly, Becton, Dickinson and Company, Animas, Insulet, F. Hoffmann-La Roche, Abbott Laboratories.
  • Information on reimbursement trends and market access for key countries.

Reasons to buy

  • Develop business strategies by understanding the trends and developments driving the global insulin delivery devices market.
  • Design and enhance your product development, marketing, and sales strategies.
  • Exploit merger and acquisition opportunities by identifying the market players with the most innovative pipelines.
  • Develop market-entry and market-expansion strategies.
  • Identify the key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return.
  • Identify, understand and capitalize on the next big thing in the insulin delivery devices market landscape.
  • Make more informed business decisions from insightful and in-depth analysis of the global insulin delivery devices market and the factors shaping it.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

3. Diabetes - Disease Overview

  • 3.1. Types of Diabetes
    • 3.1.1. Type 1 Diabetes
    • 3.1.2. Type 2 Diabetes
    • 3.1.3. Gestational Diabetes
    • 3.1.4. Signs and Symptoms
    • 3.1.5. Diabetes Diagnosis

4. Diabetes - Epidemiology

5. Global Insulin Delivery Devices Market: Device Overview

  • 5.1. Insulin Pen
    • 5.1.1. Reusable Pen
    • 5.1.2. Disposable Pen
    • 5.1.3. Pen Needle
  • 5.2. Insulin Pump
    • 5.2.1. Traditional Insulin Pump
    • 5.2.2. Disposable Insulin Pump
  • 5.3. Insulin Syringe
  • 5.4. Traditional Insulin Pump Accessories
  • 5.5. Comparison of Insulin Delivery Devices

6. Global Insulin Delivery Devices Market: Market Characterization

  • 6.1. Global Insulin Delivery Devices Market, Revenue ($bn), 2005-2012
  • 6.2. Global Insulin Delivery Devices Market, Revenue, 2012-2019
  • 6.3. Insulin Delivery Devices Market, Global, Key Company Shares, 2012
    • 6.3.1. Global
    • 6.3.2. North America
    • 6.3.3. Europe
    • 6.3.4. Asia-Pacific
  • 6.4. Insulin Delivery Devices Market, Key Trends
    • 6.4.1. Companies Move Closer to Developing Fully Automated Artificial Pancreas System
    • 6.4.2. Collaborations Foster Innovation in Insulin Delivery Devices Market
    • 6.4.3. Inhaled Rapid-Acting Insulin Studied in Research of Artificial Pancreas System
  • 6.5. Market Dynamics
    • 6.5.1. Market Drivers
    • 6.5.2. Market Restraints

7. Global Insulin Delivery Devices Market: Segment Analysis and Forecasts

  • 7.1. Insulin Pens Market, Global, Revenue, 2005-2012
  • 7.2. Insulin Pens Market, Global, Revenue, 2012-2019
  • 7.3. Insulin Pumps Market, Global, Revenue, 2005-2012
  • 7.4. Insulin Pumps Market, Global, Revenue, 2012-2019
  • 7.5. Insulin Syringes Market, Global, Revenue, 2005-2012
  • 7.6. Insulin Syringes Market, Global, Revenue, 2012-2019
  • 7.7. Traditional Insulin Pump Accessories Market, Global, Revenue, 2005-2012
  • 7.8. Traditional Insulin Pump Accessories Market, Global, Revenue, 2012-2019

8. Global Insulin Delivery Devices Market: Country Analysis and Forecasts

  • 8.1. Insulin Delivery Devices Market: Cross-country Analysis
  • 8.2. Historic and Forecast Revenue and Volume, by Country
    • 8.2.1. Insulin Delivery Devices Market, US, Revenue and Volume, 2005-2019
    • 8.2.2. Insulin Delivery Devices Market, Japan, Revenue and Volume, 2005-2019
    • 8.2.3. Insulin Delivery Devices Market, Germany, Revenue and Volume, 2005-2019
    • 8.2.4. Insulin Delivery Devices Market, France, Revenue, 2005-2012
    • 8.2.5. Insulin Delivery Devices Market, UK, Revenue and Volume, 2005-2019
    • 8.2.6. Insulin Delivery Devices Market, Spain, Revenue, Volume, 2005-2019
    • 8.2.7. Insulin Delivery Devices Market, Italy, Revenue, Volume, 2005-2019
    • 8.2.8. Insulin Delivery Devices Market, Canada, Revenue, Volume, 2005-2019
    • 8.2.9. Insulin Delivery Devices Market, China, Revenue, Volume, 2005-2019
    • 8.2.10. Insulin Delivery Devices Market, Australia, Revenue, Volume, 2005-2019
    • 8.2.11. Insulin Delivery Devices Market, India, Revenue, 2005-2012
    • 8.2.12. Insulin Delivery Devices Market, Brazil, Revenue, 2005-2019

9. Global Insulin Delivery Devices Market: Reimbursement System

  • 9.1. US
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. France
    • 9.2.3. Italy
    • 9.2.4. Spain
    • 9.2.5. UK
    • 9.2.6. Denmark
    • 9.2.7. Norway
    • 9.2.8. Sweden
    • 9.2.9. Belgium
    • 9.2.10. Netherlands
    • 9.2.11. Luxembourg
  • 9.3. Asia-Pacific

10. Global Insulin Delivery Devices Market: Competitive Landscape

  • 10.1. Comparison of Leading Insulin Pumps by Size and Color Options, 2014
  • 10.2. Comparison of Leading Insulin Pumps by Basal and Bolus Specifications, 2014
  • 10.3. Comparison of Leading Insulin Pumps by Bolus Calculator Options and Operation, 2014
  • 10.4. Novo Nordisk (Subsidiary of Novo A/S)
    • 10.4.1. Business Overview
    • 10.4.2. Marketed Products
  • 10.5. Sanofi
    • 10.5.1. Business Overview
    • 10.5.2. Marketed Products
  • 10.6. Eli Lilly
    • 10.6.1. Business Overview
    • 10.6.2. Marketed Products
  • 10.7. Medtronic
    • 10.7.1. Business Overview
    • 10.7.2. Marketed Products
  • 10.8. Becton, Dickinson and Company
    • 10.8.1. Business Overview
    • 10.8.2. Marketed Products
  • 10.9. Animas
    • 10.9.1. Business Overview
    • 10.9.2. Marketed Products
  • 10.10. F. Hoffmann-La Roche
    • 10.10.1. Business Overview
    • 10.10.2. Marketed Products
  • 10.11. Insulet
    • 10.11.1. Business Overview
    • 10.11.2. Marketed Products
  • 10.12. Asante Solutions
    • 10.12.1. Business Overview
  • 10.13. Abbott Laboratories
    • 10.13.1. Business Overview
    • 10.13.2. Marketed Products
  • 10.14. Ypsomed
    • 10.14.1. Business Overview
    • 10.14.2. Marketed Products
  • 10.15. Owen Mumford
    • 10.15.1. Business Overview
    • 10.15.2. Marketed Products
  • 10.16. Bioject Medical Technologies
    • 10.16.1. Business Overview
    • 10.16.2. Marketed Products
  • 10.17. Injex - Equidyne Systems
    • 10.17.1. Business Overview
    • 10.17.2. Marketed Products
  • 10.18. Antares Pharma
    • 10.18.1. Business Overview
    • 10.18.2. Marketed Products
  • 10.19. Tandem Diabetes Care
    • 10.19.1. Business Overview
    • 10.19.2. Marketed Products
  • 10.20. Tonghua Dongbao Pharmaceutical
    • 10.20.1. Business Overview
    • 10.20.2. Marketed Products
  • 10.21. Shanghai Fosun Pharmaceutical
    • 10.21.1. Business Overview
    • 10.21.2. Marketed Products

11. Global Insulin Delivery Devices Market: Product Pipeline Analysis

  • 11.1. Insulin Delivery Devices Market: List of Pipeline Products
    • 11.1.1. Insulin Pumps, List of Pipeline Products
    • 11.1.2. Insulin Pens, List of Pipeline Products
  • 11.2. Insulin Delivery Devices Market: Profiles of Key Pipeline Products
    • 11.2.1. 5th Generation CGM Sensor with t:slim Insulin Delivery System
    • 11.2.2. Accu-Chek Insight
    • 11.2.3. Angel Touch
    • 11.2.4. Animas Vibe Insulin Pump and CGM System
    • 11.2.5. Bolus Patch
    • 11.2.6. Cellnovo Wireless Insulin Pump System
    • 11.2.7. Freehand Patch Pump
    • 11.2.8. Insulin Pump
    • 11.2.9. InsuPatch Device
    • 11.2.10. Integrated CGM with Next Gen OmniPod System PDM
    • 11.2.11. Jewel Pump
    • 11.2.12. La Fenice E
    • 11.2.13. La Fenice V
    • 11.2.14. Lanzi
    • 11.2.15. Mini Pump
    • 11.2.16. MiniMed 640G
    • 11.2.17. MinIn
    • 11.2.18. OmniPod Insulin Pump - New Version
    • 11.2.19. Onetouch Ping Verio Insulin Pump with Meter Remote
    • 11.2.20. OneTouch with Next Gen Omnipod
    • 11.2.21. Patch Pump-1
    • 11.2.22. Patch Pump-2
    • 11.2.23. Patch Pump-3
    • 11.2.24. Spring Insulin Pump
    • 11.2.25. Spring Zone Hybrid Patch Pump
    • 11.2.26. U-Strip Insulin Patch
    • 11.2.27. Exenatide Once Weekly Pen Device
    • 11.2.28. Fix-Flex Device
    • 11.2.29. G-Pen
    • 11.2.30. G-Pen Mini
    • 11.2.31. Insulin Guard Self-Injector Safety Needle
    • 11.2.32. JuniorSTAR
    • 11.2.33. La Fenice Pen
    • 11.2.34. Levemir FlexTouch
    • 11.2.35. Next Generation Pen Needle II
    • 11.2.36. NovoLog FlexTouch

12. Global Insulin Delivery Devices Market: Consolidation Landscape

  • 12.1. Deals Summary (2004-2013)
  • 12.2. Key Deals (2009-2013)
    • 12.2.1. LifeScan Acquires Calibra Medical
    • 12.2.2. Roche Holding Acquires Medingo from Elron Electronic Industries, 2010
    • 12.2.3. Insulet Enters into Co-Development Agreement with Eli Lilly, 2013
    • 12.2.4. Tandem Diabetes Enters into Co-Development Agreement with Juvenile Diabetes Research Foundation for Dual-Chamber Infusion Pump, 2013
    • 12.2.5. Juvenile Diabetes Research Foundation Extends Co-Development Agreement with Becton, Dickinson, 2012
    • 12.2.6. Bioton and SciGen Amend Distribution Agreement with Bayer HealthCare, 2012
    • 12.2.7. Insulet Expands Distribution Agreement with Ypsomed Holding, 2012

13. Appendix

  • 13.1. Definitions
    • 13.1.1. Insulin Delivery
  • 13.2. Abbreviations
  • 13.3. Bibliography
  • 13.4. Research Methodology
    • 13.4.1. Secondary Research
    • 13.4.2. Primary Research
    • 13.4.3. Models
    • 13.4.4. Forecasts
    • 13.4.5. Expert Panel
  • 13.5. Contact Us
  • 13.6. Disclaimer

List of Tables

  • Table 1: Insulin Delivery Devices Market, Global, Diabetes National Prevalence (%) and Patient Population (million), 2013
  • Table 2: Insulin Delivery Devices Market, Global, Revenue ($bn), 2005-2012
  • Table 3: Insulin Delivery Devices Market, Global, Revenue ($bn), 2012-2019
  • Table 4: Insulin Delivery Devices Market, Global, Key Company Share by Region (%), 2012
  • Table 5: Insulin Delivery Devices Market, Number of Patients in 10 Largest Markets (Aged 29-79 Years), 2013-2035
  • Table 6: Insulin Delivery Devices Market, Health Expenditure due to Diabetes (20-79 Years) and Diabetes Population, 2013
  • Table 7: Insulin Pens Market, Global, Revenue ($bn), 2005-2012
  • Table 8: Insulin Pens Market, Global, Revenue Forecast ($bn), 2012-2019
  • Table 9: Insulin Pumps Market, Global, Revenue ($m), 2005-2012
  • Table 10: Insulin Pumps Market, Global, Revenue ($m), 2012-2019
  • Table 11: Insulin Syringes Market, Global, Revenue ($m), 2005-2012
  • Table 12: Insulin Syringes Market, Global, Revenue Forecast ($m), 2012-2019
  • Table 13: Traditional Insulin Pump Accessories Market, Global, Revenue ($m), 2005-2012
  • Table 14: Traditional Insulin Pump Accessories Market, Global, Revenue Forecast ($m), 2012-2019
  • Table 15: Insulin Delivery Devices Market, Global, Cross-country Analysis, CAGR (%), 2005-2019
  • Table 16: Insulin Delivery Devices Market, US, Revenue ($bn), Volume (million), 2005-2012
  • Table 17: Insulin Delivery Devices Market, US, Revenue ($bn), Volume (million), 2012-2019
  • Table 18: Insulin Delivery Devices Market, Japan, Revenue ($m), Volume ('000), 2005-2012
  • Table 19: Insulin Delivery Devices Market, Japan, Revenue ($m), Volume ('000), 2012-2019
  • Table 20: Insulin Delivery Devices Market, Germany, Revenue ($m), Volume ('000), 2005-2012
  • Table 21: Insulin Delivery Devices Market, Germany, Revenue ($m), Volume ('000), 2012-2019
  • Table 22: Insulin Delivery Devices Market, France, Revenue ($m), Volume ('000), 2005-2012
  • Table 23: Insulin Delivery Devices Market, France, Revenue ($m), Volume ('000), 2012-2019
  • Table 24: Insulin Delivery Devices Market, UK, Revenue ($m), Volume ('000), 2005-2012
  • Table 25: Insulin Delivery Devices Market, UK, Revenue ($m), Volume ('000), 2012-2019
  • Table 26: Insulin Delivery Devices Market, Spain, Revenue ($m), Volume ('000), 2005-2012
  • Table 27: Insulin Delivery Devices Market, Spain, Revenue ($m), Volume ('000), 2012-2019
  • Table 28: Insulin Delivery Devices Market, Italy, Revenue ($m), Volume ('000), 2005-2012
  • Table 29: Insulin Delivery Devices Market, Italy, Revenue ($m), Volume ('000), 2012-2019
  • Table 30: Insulin Delivery Devices Market, Canada, Revenue ($m), Volume ('000), 2005-2012
  • Table 31: Insulin Delivery Devices Market, Canada, Revenue ($m), Volume ('000), 2012-2019
  • Table 32: Insulin Delivery Devices Market, China, Revenue ($m), Volume ('000), 2005-2012
  • Table 33: Insulin Delivery Devices Market, China, Revenue ($m), Volume ('000), 2012-2019
  • Table 34: Insulin Delivery Devices Market, Australia, Revenue ($m), Volume ('000), 2005-2012
  • Table 35: Insulin Delivery Devices Market, Australia, Revenue ($m), Volume ('000), 2012-2019
  • Table 36: Insulin Delivery Devices Market, India, Revenue ($m), Volume ('000), 2005-2012
  • Table 37: Insulin Delivery Devices Market, India, Revenue ($m), Volume ('000), 2012-2019
  • Table 38: Insulin Delivery Devices Market, Brazil, Revenue ($m), Volume ('000), 2005-2012
  • Table 39: Insulin Delivery Devices Market, Brazil, Revenue ($m), Volume ('000), 2012-2019
  • Table 40: Novo Nordisk, Key Marketed Products, 2013
  • Table 41: Sanofi, Key Marketed Products, 2013
  • Table 42: Eli Lilly, Key Marketed Products, 2013
  • Table 43: Medtronic, Key Marketed Products, 2013
  • Table 44: Becton, Dickinson and Company, Key Marketed Products, 2013
  • Table 45: Animas, Key Marketed Products, 2013
  • Table 46: F. Hoffmann-La Roche, Key Marketed Products, 2013
  • Table 47: Insulet, Key Marketed Products, 2013
  • Table 48: Asante Solutions, Key Marketed Products, 2013
  • Table 49: Abbott Laboratories, Key Marketed Products, 2013
  • Table 50: Ypsomed Holding AG, Key Marketed Products, 2013
  • Table 51: Owen Mumford, Key Marketed Products, 2014
  • Table 52: Bioject Medical Technologies, Key Marketed Products, 2014
  • Table 53: INJEX - Equidyne Systems, Key Marketed Products, 2014
  • Table 54: Antares Pharma, Key Marketed Products, 2014
  • Table 55: Tandem Diabetes Care, Key Marketed Products, 2014
  • Table 56: Tonghua Dongbao Pharmaceutical, Key Marketed Products, 2014
  • Table 57: Shanghai Fosun Pharmaceutical, Key Marketed Products, 2014
  • Table 58: Insulin Pumps Market, Global, List of Pipeline Products, 2014
  • Table 59: Insulin Pens Market, Global, List of Pipeline Products, 2014
  • Table 60: 5th Generation CGM Sensor With t:slim Insulin Delivery System, Product Status, 2014
  • Table 61: Accu-Chek Insight, Product Status, 2014
  • Table 62: Angel Touch, Product Status, 2014
  • Table 63: Animas Vibe Insulin Pump and CGM System, Product Status, 2014
  • Table 64: Bolus Patch, Product Status, 2014
  • Table 65: Cellnovo Wireless Insulin Pump System, Product Status, 2014
  • Table 66: Freehand Patch Pump, Product Status, 2014
  • Table 67: Insulin Pump, Product Status, 2014
  • Table 68: InsuPatch Device, Product Status, 2014
  • Table 69: Integrated CGM With Next Gen OmniPod System PDM, Product Status, 2014
  • Table 70: Jewel Pump, Product Status, 2014
  • Table 71: La Fenice E, Product Status, 2014
  • Table 72: La Fenice V, Product Status, 2014
  • Table 73: Lanzi, Product Status, 2014
  • Table 74: Mini Pump, Product Status, 2014
  • Table 75: MiniMed 640G, Product Status, 2014
  • Table 76: MinIn, Product Status, 2014
  • Table 77: OmniPod Insulin Pump - New Version, Product Status, 2014
  • Table 78: Onetouch Ping Verio Insulin Pump with Meter Remote, Product Status, 2014
  • Table 79: OneTouch with Next Gen Omnipod, Product Status, 2014
  • Table 80: Patch Pump-1, Product Status, 2014
  • Table 81: Patch Pump-2, Product Status, 2014
  • Table 82: Patch Pump-3, Product Status, 2014
  • Table 83: Spring Insulin Pump, Product Status, 2014
  • Table 84: Spring Zone Hybrid Patch Pump, Product Status, 2014
  • Table 85: U-Strip Insulin Patch, Product Status, 2014
  • Table 86: Exenatide Once Weekly Pen Device, Product Status, 2014
  • Table 87: Fix-Flex Device, Product Status, 2014
  • Table 88: G-Pen, Product Status, 2014
  • Table 89: G-Pen Mini, Product Status, 2014
  • Table 90: Insulin Guard Self-Injector Safety Needle, Product Status, 2014
  • Table 91: JuniorSTAR, Product Status, 2014
  • Table 92: La Fenice Pen, Product Status, 2014
  • Table 93: Levemir FlexTouch, Product Status, 2014
  • Table 94: Next Generation Pen Needle II, Product Status, 2014
  • Table 95: NovoLog FlexTouch, Product Status, 2014

List of Figures

  • Figure 1: Insulin Delivery Devices Market, Insulin Pump Timeline, 1963-2011
  • Figure 2: Insulin Delivery Devices Market, Device Overview
  • Figure 3: Insulin Delivery Devices Market, Comparison of Insulin Therapy
  • Figure 4: Insulin Delivery Devices Market, Global, Revenue ($bn), 2005-2012
  • Figure 5: Insulin Delivery Devices Market, Global, Revenue ($bn), 2012-2019
  • Figure 6: Insulin Delivery Devices Market, Global, Key Company Share by Region (%), 2012
  • Figure 7: Insulin Delivery Devices Market, Market Trends
  • Figure 8: Insulin Delivery Devices Market, Ongoing/Completed Studies on Artificial Pancreas
  • Figure 9: Insulin Delivery Devices Market, Leading Integrated CGM-Insulin Pump Brands, 2013
  • Figure 10: Insulin Delivery Devices Market, Market Dynamics
  • Figure 11: Insulin Delivery Devices Market, Number of Patients in 10 Largest Markets (Aged 29-79 Years), 2013-2035
  • Figure 12: Insulin Delivery Devices Market, Health Expenditure due to Diabetes (20-79 Years) and Diabetes Population, 2013
  • Figure 13: Insulin Delivery Devices Market, Clinical Studies Indicating Safety and Efficacy of Insulin Pumps
  • Figure 14: Insulin Delivery Devices Market, Annual Cost of Insulin Pumps and Supplies and Annual Cost of Treatment for Serious Complications in Alberta, Canada, 2012 and 2032
  • Figure 15: Insulin Delivery Devices Market, Clinical Studies Indicating Advantages of Insulin Pens Over Syringes
  • Figure 16: Insulin Delivery Devices Market, Patient Compliance Analysis for Insulin Pens and Insulin Syringes
  • Figure 17: Insulin Pens Market, Global, Revenue ($bn), 2005-2012
  • Figure 18: Insulin Pens Market, Global, Revenue Forecast ($bn), 2012-2019
  • Figure 19: Insulin Pumps Market, Global, Revenue ($m), 2005-2012
  • Figure 20: Insulin Pumps Market, Global, Revenue Forecast ($m), 2012-2019
  • Figure 21: Insulin Syringes Market, Global, Revenue ($m), 2005-2012
  • Figure 22: Insulin Syringes Market, Global, Revenue Forecast ($m), 2012-2019
  • Figure 23: Traditional Insulin Pump Accessories Market, Global, Revenue ($m), 2005-2012
  • Figure 24: Traditional Insulin Pump Accessories Market, Global, Revenue Forecast ($m), 2012-2019
  • Figure 25: Insulin Delivery Devices Market, Global, Cross-country Analysis, CAGR (%), 2005-2019
  • Figure 26: Insulin Delivery Devices Market, US, Cross-segment Analysis, CAGR (%), 2005-2019
  • Figure 27: Insulin Delivery Devices Market, US, Revenue ($bn), Volume (million), 2005-2019
  • Figure 28: Insulin Delivery Devices Market, Japan, Cross-segment Analysis, CAGR (%), 2005-2019
  • Figure 29: Insulin Delivery Devices Market, Japan, Revenue and Volume (000s), 2005-2019
  • Figure 30: Insulin Delivery Devices Market, Germany, Cross-segment Analysis, CAGR (%), 2005-2019
  • Figure 31: Insulin Delivery Devices Market, Germany, Revenue ($m), Volume ('000), 2005-2019
  • Figure 32: Insulin Delivery Devices Market, France, Cross-segment Analysis, CAGR (%), 2005-2019
  • Figure 33: Insulin Delivery Devices Market, France, Revenue ($m), Volume ('000), 2005-2019
  • Figure 34: Insulin Delivery Devices Market, UK, Cross-segment Analysis, CAGR (%), 2005-2019
  • Figure 35: Insulin Delivery Devices Market, UK, Revenue ($m), Volume ('000), 2005-2019
  • Figure 36: Insulin Delivery Devices Market, Spain, Cross-segment Analysis, CAGR (%), 2005-2019
  • Figure 37: Insulin Delivery Devices Market, Spain, Revenue ($m), Volume ('000), 2005-2019
  • Figure 38: Insulin Delivery Devices Market, Italy, Cross-segment Analysis, CAGR (%), 2005-2019
  • Figure 39: Insulin Delivery Devices Market, Italy, Revenue ($m), Volume ('000), 2005-2019
  • Figure 40: Insulin Delivery Devices Market, Canada, Cross-segment Analysis, CAGR (%), 2005-2019
  • Figure 41: Insulin Delivery Devices Market, Canada, Revenue ($m), Volume ('000), 2005-2019
  • Figure 42: Insulin Delivery Devices Market, China, Cross-segment Analysis, CAGR (%), 2005-2019
  • Figure 43: Insulin Delivery Devices Market, China, Revenue ($m), Volume ('000), 2005-2019
  • Figure 44: Insulin Delivery Devices Market, Australia, Cross-segment Analysis, CAGR (%), 2005-2019
  • Figure 45: Insulin Delivery Devices Market, Australia, Revenue ($m), Volume ('000), 2005-2019
  • Figure 46: Insulin Delivery Devices Market, India, Cross-segment Analysis, CAGR (%), 2005-2019
  • Figure 47: Insulin Delivery Devices Market, India, Revenue ($m), Volume ('0000), 2005-2019
  • Figure 48: Insulin Delivery Devices Market, Brazil, Cross-segment Analysis, CAGR (%), 2005-2019
  • Figure 49: Insulin Delivery Devices Market, Brazil, Revenue ($m), Volume ('000), 2005-2019
  • Figure 50: Insulin Delivery Devices Market, Comparison of Leading Insulin Pumps by Size and Color Options, 2014
  • Figure 51: Insulin Delivery Devices Market, Comparison of Leading Insulin Pumps by Basal and Bolus Specifications, 2014
  • Figure 52: Insulin Delivery Devices Market, Comparison of Leading Insulin Pumps by Bolus Calculator Options and Operation, 2014
  • Figure 53: Global Insulin Delivery Devices Market, Pipeline Products Summary, 2013
  • Figure 54: Global Insulin Delivery Devices Market, Deals Summary, 2013
Back to Top